Inactive Instrument

Procter & Gamble Health Ltd Share Price NSE India S.E.

Equities

Pharmaceuticals

End-of-day quote NSE India S.E.
- INR - Intraday chart for Procter & Gamble Health Ltd
Sales 2022 11.14B 134M Sales 2023 12.3B 147M Capitalization 87.13B 1.05B
Net income 2022 1.92B 23.09M Net income 2023 2.3B 27.53M EV / Sales 2022 5.95 x
Net cash position 2022 3.17B 37.97M Net cash position 2023 4.23B 50.74M EV / Sales 2023 6.74 x
P/E ratio 2022
36.1 x
P/E ratio 2023
38 x
Employees -
Yield 2022
1.25%
Yield 2023
1.81%
Free-Float 47.83%
More Fundamentals * Assessed data
Procter & Gamble Health Limited Declares Interim Dividend for the Financial Year 2023-24, Payable on or Before March 3, 2024 CI
Procter & Gamble Health Limited Declares Special Dividend for the Financial Year 2023-24, Payable on or Before March 3, 2024 CI
Procter & Gamble Health Limited Reports Earnings Results for the Second Quarter and Six Months Ended December 31, 2023 CI
Procter & Gamble Health Limited Reports Earnings Results for the First Quarter Ended September 30, 2023 CI
Procter & Gamble Hygiene to Discontinue Injection Production at Goa, Unit, India MT
Procter & Gamble Health Limited Discontinues Production of Injections at its Manufacturing Plant in Goa Effective September 30, 2023 CI
Procter & Gamble Health's Net Profit Slumps in Fiscal Q4; Shares Dip 5% MT
Procter & Gamble Health Limited Reports Earnings Results for the Full Year Ended June 30, 2023 CI
Procter & Gamble Health Limited Reports Earnings Results for the Fourth Quarter Ended June 30, 2023 CI
Procter & Gamble Health Limited Recommends Final Dividend,Payable Between November 28, 2023 to December 18, 2023 CI
Procter & Gamble Health Limited Announces Change in Senior Management Personnel CI
Procter & Gamble India to invest $244 million to set up manufacturing facility RE
Procter & Gamble Health Limited Reports Earnings Results for the Third Quarter and Nine Months Ended March 31, 2023 CI
Procter & Gamble Health Appoints CFO MT
Procter & Gamble Health Limited Appoints Lokesh Chandak as Chief Financial Officer, Effective April 1, 2023 CI
More news
Managers TitleAgeSince
Chief Executive Officer 55 01/18/01
Director of Finance/CFO - 01/23/01
Compliance Officer - 01/21/01
Members of the board TitleAgeSince
Chairman 86 17/84/17
Director/Board Member 66 15/21/15
Director/Board Member 75 05/15/05
More insiders
Procter & Gamble Health Limited is an India-based company that is primarily engaged in the manufacturing of pharmaceutical products. The Company is engaged in the manufacturing and marketing of over-the-counter products, vitamins, minerals, and supplements products for a healthy lifestyle. The Company’s brands include Cosome, Evion, Neurobion, Seven Seas, Nasivion, Polybion, and Livogen. Cosome is a medicine which is used to help relieve dry coughs and related congestion symptoms. Evion is a Vitamin E capsules. The Evion range has different variants with different levels of Vitamin E, such as Evion 400, Evion 200, and Evion 600. Neurobion offers a range of neurotropic B-Vitamins which are a combination to help treat nerve damage and regenerate the nerves to relieve symptoms. Nasivion Classic Nasal Spray starts working on a blocked nose in 25 seconds. Polybion is a brand that helps with release and hence supports an active life.
More about the company